Arca
Skip to content

Myopia

Drug research and approvals for myopia: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 17, 2026, 122 studies of myopia are recruiting on ClinicalTrials.gov, Health Canada has authorized 0 drug trials for it since 2013, and the EU has 2 authorised medicines for it.

  • Recruiting worldwide: 122
  • Trials authorized in Canada: 0
  • FDA orphan approvals: 0
  • EU medicines: 2

Recruiting Now

Newest start dates first, of 122 recruiting on ClinicalTrials.gov ↗

Drug Pipeline

4 in phase 3, 2 in phase 2, 4 in phase 1 or earlier; from ChEMBL's drug indications, furthest stage reached for this condition
Atropine
Phase 3 Muscarinic acetylcholine receptor M3 antagonist
Acetaminophen
Phase 3 Cyclooxygenase inhibitor
Codeine
Phase 3 Opioid receptors; mu/kappa/delta agonist
Bevacizumab
Phase 3 Vascular endothelial growth factor A inhibitor
Riboflavin
Phase 2
Mitomycin
Phase 1 DNA inhibitor
Cyclopentolate
Phase 1 Muscarinic acetylcholine receptor M3 antagonist
Ranibizumab
Phase 1 Vascular endothelial growth factor A inhibitor
Pilocarpine
Early phase 1 Muscarinic acetylcholine receptor M3 agonist

How Its Trials Ended

812 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrong

Of the 71 whose ending is known, 52% met their primary endpoint, 4% missed it and 44% stopped early.

  • Completed, result not reported44154%
  • Ongoing17722%
  • Status unknown12315%
  • Met its primary endpoint375%
  • Stopped: other or unclear202%
  • Stopped: enrollment or feasibility40%
  • Missed its primary endpoint30%
  • Stopped: sponsor or business decision30%
  • Stopped: lack of efficacy20%
  • Stopped: safety10%
  • Stopped: funding10%

Medicines Authorised in the EU

Newest first
Jun 2, 2025RyjuneaAtropine sulfateSanten OyEMA ↗
Jul 27, 2000VisudyneVerteporfinCHEPLAPHARM Arzneimittel GmbHEMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.